Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak Almeida

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 12, 2002
Drug-resistant tuberculosis in IndiaDeepak Almeida, Zarir F Udwadia, Camilla Rodrigues, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2007
In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosisDeepak Almeida, Eric Nuermberger, Sandeep Tyagi, et al.
American Journal of Respiratory and Critical Care Medicine|August 30, 2008
Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?Ian M Rosenthal, Ming Zhang, Deepak Almeida, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2005
High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, IndiaDeepak Almeida, Camilla Rodrigues, Tester F Ashavaid, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2003
Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for preventionDeepak Almeida, Camilla Rodrigues, Zarir F Udwadia, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2009
Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosisDeepak Almeida, Eric Nuermberger, Rokeya Tasneen, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2023
Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosisDeepak Almeida, Si-Yang Li, Jin Lee, et al.
Plos Neglected Tropical Diseases|January 20, 2011
Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in miceDeepak Almeida, Paul J Converse, Zahoor Ahmad, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosisEric Nuermberger, Sandeep Tyagi, Rokeya Tasneen, et al.
Antimicrobial Agents and Chemotherapy|September 27, 2021
Comparative Efficacy of the Novel Diarylquinoline TBAJ-876 and Bedaquiline against a Resistant <i>Rv0678</i> Mutant in a Mouse Model of TuberculosisDeepak Almeida, Paul J Converse, Si-Yang Li, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 12, 2002
Drug-resistant tuberculosis in IndiaDeepak Almeida, Zarir F Udwadia, Camilla Rodrigues, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2007
In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosisDeepak Almeida, Eric Nuermberger, Sandeep Tyagi, et al.
American Journal of Respiratory and Critical Care Medicine|August 30, 2008
Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?Ian M Rosenthal, Ming Zhang, Deepak Almeida, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2005
High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, IndiaDeepak Almeida, Camilla Rodrigues, Tester F Ashavaid, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2003
Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for preventionDeepak Almeida, Camilla Rodrigues, Zarir F Udwadia, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2009
Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosisDeepak Almeida, Eric Nuermberger, Rokeya Tasneen, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2023
Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosisDeepak Almeida, Si-Yang Li, Jin Lee, et al.
Plos Neglected Tropical Diseases|January 20, 2011
Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in miceDeepak Almeida, Paul J Converse, Zahoor Ahmad, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosisEric Nuermberger, Sandeep Tyagi, Rokeya Tasneen, et al.
Antimicrobial Agents and Chemotherapy|September 27, 2021
Comparative Efficacy of the Novel Diarylquinoline TBAJ-876 and Bedaquiline against a Resistant <i>Rv0678</i> Mutant in a Mouse Model of TuberculosisDeepak Almeida, Paul J Converse, Si-Yang Li, et al.
Pageof 3